Glenmark Pharmaceuticals Limited (GLENMARK.NS) NSE

2,011.30

+3.1(+0.15%)

Updated at January 14 03:30PM

Currency In INR

Valuation

Market Cap425.88B
Enterprise Value433.85B
P/E Ratio56.25
PEG Ratio1.65
Price/Sales Ratio3.57
Price/Book Ratio5.93
Enterprise/Revenue3.48
Enterprise/EBITDA22.12

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.2

Management Effectiveness

Return On Assets0.05
Return On Equity0.11

Income Statement

Revenue133.63B
Revenue/Share564.38
Gross Profit88.38B
EBITDA21.68B
Net Income10.47B
Diluted EPS37.11

Balance Sheet

Total Cash29.58B
Total Cash/Share104.84
Total Debt12.24B
Total Debt/Equity0.13
Current Ratio1.65
Book Value Per Share339.56

Price History

52-Week Change32.79
52-Week High2,284.8
52-Week Low1,275.5
Moving Average 50 Days1,952.19
Moving Average 200 Days1,832.47

Statistics

Average Volume818,778
Shares Outstanding282.2M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.25
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 10, 2007